Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202

BACKGROUND: In prostate cancer, end points that reliably portend prognosis and treatment benefit (surrogate end points) can accelerate therapy development. Although surrogate end point candidates have been evaluated in the context of radiotherapy and short-term androgen deprivation (AD), potential s...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Oncol
Hoofdauteurs: Dignam, James J., Hamstra, Daniel A., Lepor, Herbert, Grignon, David, Brereton, Harmar, Currey, Adam, Rosenthal, Seth, Zeitzer, Kenneth L., Venkatesan, Varagur M., Horwitz, Eric M., Pisansky, Thomas M., Sandler, Howard M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2019
Onderwerpen:
ORIGINAL REPORTS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6338393/
https://ncbi.nlm.nih.gov/pubmed/30526194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.18.00154
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items